IM Cannabis Sets 3:1 Reverse Split for Nov 23 to Chase $1 Nasdaq Floor
IMCC sits 19% above its 52-week low of $0.45.
Summary
The board approved a 3:1 share consolidation on November 18, 2026, with the company expecting November 23, 2026 to be the effective date, cutting shares outstanding from 1,844,162 to roughly 614,721, subject to rounding. The stated purpose is to lift the per-share price above Nasdaq's $1.00 minimum bid; the stock closed at $0.5356, so a 3:1 ratio only gets it to about $1.61 on paper. The post-consolidation CUSIP becomes 44969Q604 and the ISIN CA44969Q6040, no fractional shares will be issued with fractions of one-half or more rounded up, and the name and symbol IMCC stay unchanged, with trading on a post-consolidation basis anticipated to begin on Nasdaq at the opening on November 23, 2026, subject to final confirmation from Nasdaq. The bigger problem: because IMCC already did a 30:1 consolidation on August 27, 2026, it is not eligible for a fresh 180-day compliance period — 30 consecutive business days below $1.00 would trigger a Staff Delisting Determination. This lands on top of a brutal stretch: Q3 continuing-operations revenue fell 68% year over year to C$1.65M with a small gross loss, and the company has been funding itself through discounted convertibles and heavy resale registrations, including 25.3 million shares registered for L.I.A. Pure Capital on November 10. A reverse split into a dilutive, shrinking-revenue story rarely holds the bid; watch whether the post-split price stays above $1.00 after trading begins November 23.
Updated with an SEC 6-K filing · What changed
Updates
· SEC 6-K — Post-consolidation CUSIP changes to 44969Q604 and ISIN to CA44969Q6040; no fractional shares issued, with fractions of one-half or more rounded up.
- Consolidation Ratio — One post-consolidated Common Share for every three pre-consolidated shares; issued and outstanding shares expected to fall from 1,844,162 to approximately 614,721, subject to rounding.
- Key Dates — The board approved the Consolidation on November 18, 2026, and the Company currently expects November 23, 2026 to be the Effective Date; post-Consolidation trading on Nasdaq is anticipated to begin at the opening on November 23, 2026, subject to final confirmation from Nasdaq.
- Nasdaq Bid Compliance — The primary purpose is to increase the per-share trading price to support compliance with Nasdaq's US$1.00 minimum bid; a company that effected a reverse split in the prior one-year period, as with the August 27, 2026 30:1 consolidation, is not eligible for the 180-calendar-day compliance period, and 30 consecutive business days below US$1.00 would bring a Staff Delisting Determination.
- Convertible Adjustments — Exercise and/or conversion prices and the number of Common Shares issuable under outstanding convertible, exchangeable or exercisable securities will be proportionately adjusted per their terms.
- Shareholder Exchange — Registered shareholders as of the Effective Date will receive a letter of transmittal from Computershare Investor Services Inc. with exchange instructions; the name and symbol "IMCC" remain unchanged.
All 10 details
- Exercise price and/or conversion price and number of Common Shares issuable under outstanding convertible, exchangeable or exercisable securities will be proportionately adjusted in connection with the Consolidation in accordance with their respective terms.
- Registered shareholders as of the Effective Date will receive a letter of transmittal from Computershare Investor Services Inc., the registrar and transfer agent, with instructions for exchanging their Common Shares.
- Board approved the Consolidation on November 18, 2026; Company currently expects November 23, 2026 to be the Effective Date.
- Common Shares anticipated to begin trading on Nasdaq on a post-Consolidation basis at the opening of trading on November 23, 2026, subject to final confirmation from Nasdaq.
- Company's name and existing stock symbol "IMCC" will remain unchanged.
- Consolidation ratio: one post-consolidated Common Share for every three pre-consolidated Common Shares.
- Issued and outstanding Common Shares expected to fall from 1,844,162 to approximately 614,721, subject to rounding.
- Primary purpose is to increase the per-share trading price to support compliance with Nasdaq's US$1.00 minimum bid price requirement.
- Under Nasdaq Listing Rule 5810(c)(3)(A)(iv), a company is not eligible for the 180-calendar-day compliance period if it has effected a reverse share split during the prior one-year period; on August 27, 2026, the Company effected a 30:1 share consolidation.
- If the closing bid price is below US$1.00 per share for 30 consecutive business days, Nasdaq Staff would issue a Staff Delisting Determination.
At the time of this announcement, IMCC was trading at $0.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $864.3K. The 52-week trading range was $0.45 to $62.40. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.